This project received support from the National Cancer Institute, including the CAPAC Program (R25CA240120), Diversity Supplement (3R21CA264606-01S1), and U54CA096297. Additionally, funding was provided by the National Institute on Minority Health and Health Disparities through the RCMI Program (U54MD007600). The National Human Genome Research Institute contributed support through the Increasing Diversity in Genomics for the Next Generation (IDGeNe) program (R25HG012702). Furthermore, the study received backing from the Federal Department of Education's Developing Hispanic-Serving Institutions Program - Title V (PO31S200104). Special appreciation goes to Dr. Carlos Falcón Camacho, Dr. Ramón González García, staff and personnel at PR CoNCRA, and the Hispanic Alliance for Clinical & Translational Research (U54GM133807) for their invaluable support in recruitment, training and specimen collection, with sincere gratitude extended to our study participants.

​

​